Vet survey shows outlook is better - Morgan Stanley
Tweet
Share
E-mailGet Alerts ZTS Hot Sheet
Price: $76.04 --0%
Rating Summary:
19 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 3
Rating Summary:
19 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 3
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright notes a proprietary AlphaWise US vet survey points to sequentially lighter 1Q demand, but they are encouraged the NTM and next quarter's outlook are trending upward.
The firm favors Zoetis (NYSE: ZTS) and IDEXX Labs (NASDAQ: IDXX) into earnings, despite the recent moves higher in the stocks.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts Allwyn AG (ALWN:GA) at Hold
- Shake Shack (SHAK) Tops Q2 EPS by 10c, Offers Guidance
- Dianthus Therapeutics (DNTH) PT Raised to $131 at Raymond James
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan Stanley, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
